Non-medical and illicit use of psychoactive drugs
This volume is devoted to descriptions of non medical as well as medical uses for some drugs that have typically, or not so typically, been associated with drug abuse. One major objective of this book is to identify costs and benefits of drug abuse. The book highlights drugs including 3,4 methylened...
Saved in:
Other Authors: | , , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Cham, Switzerland :
Springer,
[2017]
|
Series: | Current topics in behavioral neurosciences ;
v. 34. |
Subjects: | |
ISBN: | 9783319600161 9783319600147 |
Physical Description: | 1 online resource |
LEADER | 05575cam a2200505Mi 4500 | ||
---|---|---|---|
001 | 97569 | ||
003 | CZ-ZlUTB | ||
005 | 20240914110656.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 170815t20172017sz o 000 0 eng d | ||
040 | |a YDX |b eng |e pn |c YDX |d N$T |d EBLCP |d GW5XE |d OCLCF |d UAB |d AZU |d UPM |d MERER |d GZM |d ESU |d OCLCO |d IOG |d OCLCO |d NJR |d COO |d JG0 |d OCLCO |d OCLCA |d U3W |d CAUOI |d OCLCQ |d KSU |d VT2 |d OCLCO |d WYU |d UKAHL |d OCLCQ |d OCLCO |d ADU |d OCLCQ |d OCLCA |d OCLCQ | ||
020 | |a 9783319600161 |q (electronic bk.) | ||
020 | |z 9783319600147 | ||
024 | 7 | |a 10.1007/978-3-319-60016-1 |2 doi | |
035 | |a (OCoLC)1006316653 |z (OCoLC)1001277724 |z (OCoLC)1001309566 |z (OCoLC)1001331830 |z (OCoLC)1004070781 |z (OCoLC)1048186870 |z (OCoLC)1112837932 |z (OCoLC)1160049452 |z (OCoLC)1162770992 | ||
245 | 0 | 0 | |a Non-medical and illicit use of psychoactive drugs / |c Suzanne Nielsen, Raimondo Bruno, Susan Schenk, editors. |
264 | 1 | |a Cham, Switzerland : |b Springer, |c [2017] | |
264 | 4 | |c ©2017 | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a počítač |b c |2 rdamedia | ||
338 | |a online zdroj |b cr |2 rdacarrier | ||
490 | 1 | |a Current Topics in Behavioral Neurosciences, |x 1866-3370 ; |v volume 34 | |
505 | 0 | |a Preface; New Directions in Substance Use-the Blurring of the Lines between Illicit and Therapeutic Drugs; Non-medical Use of Therapeutic Substances; New Ways of Approaching 'Illicit Drugs'; Future Directions; References; Contents; 447 Preclinical Effects of Antipsychotic Drugs; Abstract; 1 Introduction; 2 The Binding Profile of Antipsychotics; 3 Behavioural Test for the Therapeutic Effects of Antipsychotics; 4 Antipsychotic Drugs and Drug Discrimination; 5 Behavioural Tests for the Side Effect of Antipsychotics; References | |
505 | 8 | |a 421 Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use DisorderAbstract; References; 448 The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research; Abstract; 1 Brief Historical View of Opioid Abuse Potential Evaluation; 2 Abuse Potential Evaluation: Methods; 3 Full Mu Opioid Agonists; 4 Mu Opioid Partial Agonists; 4.1 Buprenorphine: A Case Study; 5 Mixed Opioid Agonists/Antagonists; 6 Atypical Opioid Agonists; 6.1 Abuse-Deterrent Formulations (ADFs) and Abuse Potential Testing | |
505 | 8 | |a 7 SummaryReferences; 422 Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between; Abstract; 1 Codeine Pharmacology; 2 Codeine Availability; 3 Non-medical Use and Dependence; 4 Harms from High-Dose Consumption of Over-the-Counter Codeine; 4.1 Evidence for Effectiveness; 5 Responses to Problematic Over-the-Counter Codeine Use; 5.1 Increased Restrictions on Sales; 5.2 Harm Reduction; 5.3 Challenges for Pharmacists; 5.4 Screening and Brief Intervention; 5.5 Monitoring of Sales as Part of a Comprehensive Response; Funding Acknowledgement; References | |
505 | 8 | |a 470 Injection of Pharmaceuticals Designed for Oral Use: Harms Experienced and Effective Harm Reduction Through FiltrationAbstract; 1 Introduction: Illicit Injection of Pharmaceuticals; 2 Thrombosis and Inflammation; 3 Embolism and Ischaemia; 4 Injection Site and Blood Vessels; 5 Pulmonary System; 6 Infections; 7 Filtration as a Harm Reduction Measure; 8 General Filtering Study Methodology; 8.1 Survey of People Who Inject Drugs; 8.2 Drug Extraction and Filtration; 8.3 Analysis of Particle Content; 8.4 Analysis of Active Drug Content; 8.5 Drugs Examined; 8.6 Bacterial Suspension; 9 Results | |
505 | 8 | |a 9.1 Filtration Methods Used by PWID9.2 Particulate Contamination Following Filtration; 10 Summary and Conclusions; Acknowledgements; References; 426 Misuse of Methylphenidate; Abstract; 1 Introduction; 1.1 Attention-Deficit/Hyperactivity Disorder (ADHD); 1.2 Link Between ADHD Neurobiology, Medication Mechanism, and Abuse Potential; 1.3 Prevalence of ADHD Stimulant Medication Misuse; 2 Methylphenidate Misuse; 2.1 Methylphenidate Abuse Liability; 2.2 Methylphenidate Diversion and Misuse; 2.3 Methylphenidate Misuse Safety Concerns; 3 Discussion; 3.1 Malingering | |
506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
520 | |a This volume is devoted to descriptions of non medical as well as medical uses for some drugs that have typically, or not so typically, been associated with drug abuse. One major objective of this book is to identify costs and benefits of drug abuse. The book highlights drugs including 3,4 methylenedioxymethamphetamine (MDMA), cannabinoids, opioids and methylphenidate because of their well-documented potential for abuse and provides new and emerging evidence of their potential to treat some chronic disease states alongside the potential consequences of exposure. | ||
590 | |a SpringerLink |b Springer Complete eBooks | ||
650 | 0 | |a Psychotropic drugs. | |
650 | 0 | |a Drug abuse. | |
655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
655 | 9 | |a electronic books |2 eczenas | |
700 | 1 | |a Nielsen, Suzanne, |e editor. | |
700 | 1 | |a Bruno, Raimondo, |e editor. | |
700 | 1 | |a Schenk, Susan, |e editor. | |
776 | 0 | 8 | |i Print version: |z 9783319600147 |z 3319600141 |w (OCoLC)987282556 |
830 | 0 | |a Current topics in behavioral neurosciences ; |v v. 34. | |
856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-319-60016-1 |y Plný text |
992 | |c NTK-SpringerBLS | ||
999 | |c 97569 |d 97569 | ||
993 | |x NEPOSILAT |y EIZ |